- Home
- CRVS vs ILPT Comparison
CRVS vs ILPT Comparison
Compare CRVS & ILPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- ILPT
- Stock Information
- Founded
- CRVS 2014
- ILPT 2017
- Country
- CRVS United States
- ILPT United States
- Employees
- CRVS N/A
- ILPT N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- ILPT Real Estate Investment Trusts
- Sector
- CRVS Health Care
- ILPT Real Estate
- Exchange
- CRVS Nasdaq
- ILPT Nasdaq
- Market Cap
- CRVS 305.4M
- ILPT 380.8M
- IPO Year
- CRVS 2016
- ILPT 2018
- Fundamental
- Price
- CRVS $5.75
- ILPT $6.16
- Analyst Decision
- CRVS Strong Buy
- ILPT
- Analyst Count
- CRVS 4
- ILPT 0
- Target Price
- CRVS $15.00
- ILPT N/A
- AVG Volume (30 Days)
- CRVS 518.7K
- ILPT 538.8K
- Earning Date
- CRVS 08-07-2025
- ILPT 10-28-2025
- Dividend Yield
- CRVS N/A
- ILPT 0.65%
- EPS Growth
- CRVS N/A
- ILPT N/A
- EPS
- CRVS N/A
- ILPT N/A
- Revenue
- CRVS N/A
- ILPT $443,468,000.00
- Revenue This Year
- CRVS N/A
- ILPT $3.44
- Revenue Next Year
- CRVS N/A
- ILPT $1.78
- P/E Ratio
- CRVS N/A
- ILPT N/A
- Revenue Growth
- CRVS N/A
- ILPT 0.36
- 52 Week Low
- CRVS $2.54
- ILPT $2.45
- 52 Week High
- CRVS $10.00
- ILPT $6.32
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- ILPT 62.18
- Support Level
- CRVS $5.28
- ILPT $5.83
- Resistance Level
- CRVS $5.64
- ILPT $6.16
- Average True Range (ATR)
- CRVS 0.30
- ILPT 0.22
- MACD
- CRVS 0.03
- ILPT -0.01
- Stochastic Oscillator
- CRVS 77.70
- ILPT 78.38
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.